durapatite has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogdanov, L; Gruzdeva, O; Kutikhin, A; Shishkova, D; Sinitsky, M; Tsepokina, A; Velikanova, E | 1 |
| Adamiano, A; Aiello, M; Barandalla-Sobrados, M; Carullo, P; Catalucci, D; Iafisco, M; Marrella, A; Miragoli, M; Rossi, S; Scaglione, S; Tampieri, A | 1 |
| Jahnen-Dechent, W; Ketteler, M; Westenfeld, R | 1 |
| Bajpai, PK; Benghuzzi, HA; England, BG | 1 |
1 review(s) available for durapatite and Cardiovascular Diseases
| Article | Year |
|---|---|
Vascular calcification and fetuin-A deficiency in chronic kidney disease.
Topics: alpha-2-HS-Glycoprotein; Blood Proteins; Calcification, Physiologic; Cardiovascular Diseases; Durapatite; Gene Regulatory Networks; Humans; Kidney Failure, Chronic; Phosphorus; Risk Factors | 2007 |
3 other study(ies) available for durapatite and Cardiovascular Diseases
| Article | Year |
|---|---|
Calcium Phosphate Bions Cause Intimal Hyperplasia in Intact Aortas of Normolipidemic Rats through Endothelial Injury.
Topics: Alanine Transaminase; Animals; Aorta; Aspartate Aminotransferases; Calcium Phosphates; Cardiovascular Diseases; Durapatite; Male; Neointima; Rats; Rats, Wistar; Risk Factors | 2019 |
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Cell Line; Delayed-Action Preparations; Drug Carriers; Durapatite; Electromagnetic Fields; Humans; Magnetite Nanoparticles; Male; Myocytes, Cardiac; Rats, Sprague-Dawley | 2018 |
Controlled release of hydrophilic compounds by resorbable and biodegradable ceramic drug delivery devices.
Topics: Biodegradation, Environmental; Biological Products; Calcium Phosphates; Cardiovascular Diseases; Ceramics; Delayed-Action Preparations; Drug Delivery Systems; Durapatite; Epinephrine; Humans; Hydroxyapatites; Minerals | 1992 |